Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy

Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy

<b>Background:</b> The aim of the study was to investigate a series of complete blood cell count-based biomarkers of systemic inflammation as predictors of clinical outcomes in patients who underwent first-line chemoimmunotherapy for advanced NSCLC. <b>Methods:</b> Consecutiv...

Full description

Bibliographic Details
Main Authors: Carlo Putzu, Riccardo Serra, Rachele Campus, Giovanni Maria Fadda, Claudio Sini, Andrea Marongiu, Giorgio Carlo Ginesu, Alessandro Giuseppe Fois, Giuseppe Palmieri, Angelo Zinellu, Antonio Cossu, Panagiotis Paliogiannis
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Current Oncology
Subjects:
lung cancer
chemotherapy
immunotherapy
NLR
MNR
biomarkers
Online Access:https://www.mdpi.com/1718-7729/31/9/367

Internet

https://www.mdpi.com/1718-7729/31/9/367

Similar Items